Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer
Immunotherapy, which stimulates the body’s immune system, has received a considerable amount of press in recent years because of its powerful benefits. Cancer immunotherapy has shown long-term results in patients with advanced disease that are not seen with traditional chemotherapy. Immune checkpoin...
Main Authors: | Md. Mominur Rahman, Tapan Behl, Md. Rezaul Islam, Md. Noor Alam, Md. Mohaimenul Islam, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Simona Gabriela Bungau |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/12/3798 |
Similar Items
-
Cytokines in Cancer Immunotherapy
by: Sylvia Lee, et al.
Published: (2011-10-01) -
POSSIBILITIES OF REPLACEMENT INTERFERON THERAPY TO TREAT ATOPIC DERMATITIS IN IMMUNOCOMPROMISED PATIENTS
by: L. P. Sizyakina, et al.
Published: (2017-07-01) -
Recent Advances in Molecular Mechanisms of Cancer Immunotherapy
by: Mateusz Kciuk, et al.
Published: (2023-05-01) -
The Urothelial Transcriptomic Response to Interferon Gamma: Implications for Bladder Cancer Prognosis and Immunotherapy
by: Simon C. Baker, et al.
Published: (2022-10-01) -
Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends
by: Tapan Behl, et al.
Published: (2022-06-01)